Human Genome Sciences, Inc.

Form 483 issued March 15, 2019 · Rockville, Maryland

Inspection
Mar 15, 2019
Observations
2
Pages
1
FEI number
3003782237

In short: On March 15, 2019, FDA issued a Form 483 with 2 observations to Human Genome Sciences, Inc. in Rockville, Maryland (FEI 3003782237) after an inspection that ran Mar 15, 2019. The investigators were Andrea Siegel, Jennifer Swisher, Madushini Dharmasena, Scott R. Nichols and Shadia Zaman. Most observations concern quality system and production.

At a glance

Quality system and production account for 2 of 2 observations.

Quality system1
Production1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a lack of quality oversight in the review of records and procedures followed in…

  2. 02

    Written procedures are not followed during manufacturing operations…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Human Genome Sciences, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected Human Genome Sciences, Inc.?

Andrea Siegel, Jennifer Swisher, Madushini Dharmasena, Scott R. Nichols and Shadia Zaman are named on this Form 483, for the inspection of Mar 15, 2019. Each investigator has a profile showing what they cite most.

When was Human Genome Sciences, Inc. inspected by FDA?

The inspection ran Mar 15, 2019, and the Form 483 is dated March 15, 2019.

How do I get the full Form 483 for Human Genome Sciences, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free